Health Law & Policy

4/2 Webinar: Examining Hepatitis C Virus Treatment Access

Examining Hepatitis C Virus Treatment Access: A Review of Select State Medicaid Fee-For-Service and Managed Care Programs   When: Thursday, April 2, 2015 3:00 – 4:30 PM EST (2:00 – 3:30 PM CST/12:00 – 1:30 PM PST) What: The arrival of an HCV cure is an exciting development for the millions of Americans who suffer […]

CHLPI Welcomes Visiting Scholar Karolina Gombert

The Center for Health Law and Policy Innovation is pleased to welcome Karolina Gombert,  a PhD student from the University of Aberdeen in Scotland, to Boston. Karolina is a recipient of Santander’s Mobility Award, given to postgraduate research students to help them gain the experience of a period of short-term study or research at a like-minded institution […]

PATHS Toward Successful Policy Advocacy: CHLPI Hosts Workshop at Together on Diabetes™ Summit

The Center for Health Law and Policy Innovation team presented a half-day Policy Advocacy Workshop at the Bristol-Myers Squibb Foundation’s Together on Diabetes™ Summit. Three Harvard Law School students reflect on the day and the important work performed by the attendees as they sought to refine and develop implementation plans for their policy goals. ————– By: Kristen Gurley […]

13 Million Americans at Risk of Losing Health Insurance in King v. Burwell

On Wednesday, March 4th, the Supreme Court begins deliberations in King v. Burwell, a legal case that threatens to strip away premium subsidies from two-thirds of states, thus putting low- to moderate-income Americans at risk of losing the health care coverage that was fought for through the Affordable Care Act. At the core of CHLPI’s […]

CHLPI Presents to the Presidential Advisory Council on HIV and AIDS on Alarming Trends in the Health Insurance Marketplaces

On February 12, 2015, Representatives from Harvard Law School’s Center for Health Law and Policy Innovation (CHLPI) presented to the members of the Presidential Advisory Council on HIV/AIDS (PACHA) during a two-day long meeting on progress and challenges to the council’s charter of advancing the prevention and cure of HIV and AIDS and ensuring that […]

Progress on New Jersey Diabetes Legislation

By Katie Garfield (CHLPI Clinical Fellow, JD ‘11) On Thursday, February 5, New Jersey took an important first step towards the goal of providing key diabetes services to its Medicaid beneficiaries. In a hearing session, the Assembly Health and Senior Services Committee of the New Jersey legislature approved the text Assembly Bill 3460. If passed, […]

The Center for Health Law and Policy Innovation Presents to the Presidential Advisory Council on HIV and AIDS on Alarming Trends in the Health Insurance Marketplaces

by Michael Wysolmerski (JD ’16) On January 12, 2015, I attended the 55th Presidential Advisory Council on HIV/AIDS (PACHA) in Washington, D.C. I attended the panel titled 2015 Healthcare Marketplace: A Review of Essential Health Benefits and Provider Networks. My supervisor at CHLPI, Carmel Shachar, presented on the panel, along with Doug Wirth, President and CEO […]

RA Position for Mental Health and Reproductive Rights in International Law (Spanish Required)

The Center for Health Law and Policy Innovation is seeking a research assistant to help analyze the role of mental health and reproductive rights in international law.  In particular, the analysis will focus on national and international law related to countries in Central and South America.  All applicants should therefore have sufficient Spanish fluency to […]

CHLPI Delivers Keynote at 7th Annual Hunger Action Summit

On January 30th, Robert Greenwald, clinical Professor of Law and Director of the Center for Health Law and Policy Innovation, was the keynote speaker at the 7th Annual Hunger Action Summit sponsored by the Second Harvest Food Bank of Santa Clara and San Mateo Counties and held at Santa Clara University. Robert’s presentation highlighted efforts to secure […]

The Sacramento Bee: Hepatitis C Drug’s High Cost Hits California Budget

The Sacramento Bee January 16, 2015 Hepatitis C drug’s high cost hits California budget “Last year, after the Food and Drug Administration approved a breakthrough new drug for hepatitis C, health officials around the country warned of dire consequences for state budgets. The drug is expensive – about $1,000 a pill, or $84,000 for a […]